Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Management Review
|
July 10, 1983
Companies prescribe major revisions in medical benefits programs to cut soaring healthcare costs
G Tavernier
Management Review
|
October 8, 1983
An aggressive management approach to healthcare cost containment
G Tavernier
Fundamental & Clinical Pharmacology
|
January 1, 1995
Regulation of beta 3-adrenoceptor expression in white fat cells
D Langin, G Tavernier, M Lafontan
Acta Psychologica
|
March 1, 1992
Effects of multiple reference points in spatial stimulus-response compatibility
K Lamberts, G Tavernier, G d'Ydewalle
Fundamental & Clinical Pharmacology
|
January 1, 1993
A study of alpha 1- and alpha 2-adrenoceptor responsiveness in diabetic insipidus dogs
G Tavernier, J M Sénard, J L Montastruc, et al.
The Journal of Clinical Investigation
|
July 15, 1996
Functional beta3-adrenoceptor in the human heart
C Gauthier, G Tavernier, F Charpentier, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1992
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms
G Tavernier, J Galitzky, A Bousquet-Melou, et al.
The Journal of Biological Chemistry
|
March 27, 1999
Testis expression of hormone-sensitive lipase is conferred by a specific promoter that contains four regions binding testicular nuclear proteins
R Blaise, J Grober, P Rouet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1992
[Differential regulation of the release of norepinephrine and neuropeptide Y]
G Tavernier, C Damase-Michel, M A Tran, et al.
European Journal of Pharmacology
|
March 17, 1992
Release of neuropeptide Y and noradrenaline during afferent nerve stimulation
P Montastruc, C Damase-Michel, G Tavernier, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Management Review
|
July 10, 1983
Companies prescribe major revisions in medical benefits programs to cut soaring healthcare costs
G Tavernier
Management Review
|
October 8, 1983
An aggressive management approach to healthcare cost containment
G Tavernier
Fundamental & Clinical Pharmacology
|
January 1, 1995
Regulation of beta 3-adrenoceptor expression in white fat cells
D Langin, G Tavernier, M Lafontan
Acta Psychologica
|
March 1, 1992
Effects of multiple reference points in spatial stimulus-response compatibility
K Lamberts, G Tavernier, G d'Ydewalle
Fundamental & Clinical Pharmacology
|
January 1, 1993
A study of alpha 1- and alpha 2-adrenoceptor responsiveness in diabetic insipidus dogs
G Tavernier, J M Sénard, J L Montastruc, et al.
The Journal of Clinical Investigation
|
July 15, 1996
Functional beta3-adrenoceptor in the human heart
C Gauthier, G Tavernier, F Charpentier, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1992
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms
G Tavernier, J Galitzky, A Bousquet-Melou, et al.
The Journal of Biological Chemistry
|
March 27, 1999
Testis expression of hormone-sensitive lipase is conferred by a specific promoter that contains four regions binding testicular nuclear proteins
R Blaise, J Grober, P Rouet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1992
[Differential regulation of the release of norepinephrine and neuropeptide Y]
G Tavernier, C Damase-Michel, M A Tran, et al.
European Journal of Pharmacology
|
March 17, 1992
Release of neuropeptide Y and noradrenaline during afferent nerve stimulation
P Montastruc, C Damase-Michel, G Tavernier, et al.
Page
of 4